Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Cellectar Biosciences
Company

Cellectar Biosciences

Tracked across 1 events · 6 articles · First seen Jul 30, 2026 · Last active Aug 13, 2026

Sentiment
40
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 40
Business
Cellectar Q2 2026 Results and Pipeline Update
Cellectar Biosciences, a late-stage clinical biopharmaceutical company, announced its second quarter 2026 financial results and provided a corporate update on August 13, 2026. The company reported cash and cash equivalents of $34.0 million as of…
Impact: Cellectar reported Q2 2026 results, highlighting a strengthened balance sheet and advancing pipeline. The company's cash runway and clinical progress are key to its valuation.
Jul 30, 2026 · 6 articles
Key Actions (6)
90 Cellectar Biosciences initiated site activationCellectar Q2 2026 Results...
85 Cellectar Biosciences planned NDA submission United States — Food and Drug AdministrationCellectar Q2 2026 Results...
80 Cellectar Biosciences reported financial resultsCellectar Q2 2026 Results...
75 Cellectar Biosciences initiated enrollmentCellectar Q2 2026 Results...
70 Cellectar Biosciences presented dataCellectar Q2 2026 Results...
50 Cellectar Biosciences published Phase 1 dataCellectar Q2 2026 Results...
ERGEN INTELLIGENCE
Track Cellectar Biosciences live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.